Ontak and Targretin Warning Letter

First Page		Document Content
Denileukin diftitox Cutaneous T-cell lymphoma Organic chemistry Bexarotene Mycosis fungoides Methadone Lymphoma Medicine Chemistry		Ontak and Targretin Warning Letter Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 118,90 KB Share Document on Facebook

	FOR IMMEDIATE RELEASE The Gores Group Completes Sale of Therakos Leading Immunotherapy Company Achieved Significant Growth Following Carve-out from Former Division of Johnson & Johnson LOS ANGELES, CA, September 28, 2015 DocID: 1n4NJ - View Document
	Award ID: CP130023 Project Title: Novel Ceramide-modulating Therapeutics for Cancer Use Award Mechanism: Company Formation DocID: 19Xk6 - View Document
	Legend Non-Hodgkin Lymphoma (NHL) Open to AccrualPh 2b Open-label, Randomized Two Arm Study of Selinexor plus Low DocID: 18GfX - View Document
	Mesothelioma Articles - Merck & Co: Zolinza becomes first app... DocID: 18oWB - View Document
	Summary of ARC Future Fellowships Proposals for Funding to Commence inVictoria Ludwig Institute for Cancer Research Limited FT0992234 DocID: 17ylH - View Document